Peter Wittner, B.Sc., is an independent consultant specialising in the commercial aspects of generics with more than 35 years’ pharmaceutical experience. Before starting his own business, Peter headed the European sales and marketing departments of the UK generics companies Evans Medical and H.N. Norton, which later became part of IVAX. He later joined the Indian generic leader Ranbaxy as Managing Director to help set up its UK business and then returned to consultancy work. Interpharm advises new market entrants on generic strategies, assists in business development for generic companies based outside the EU that are trying to enter the market and works with companies that are seeking to enlarge their product range. While mainly oriented to the commercial side with services such as market intelligence and pricing overviews for example, Interpharm also advises on IP and patent issues as well as the legal background to the pharmaceutical industry in Europe and the US. On the other side of the equation, Interpharm has also worked with originator companies that are looking at ways of defending their major brands from generic incursion.